| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |